APA (7th ed.) Citation

Fujimoto, N., Sugimoto, T., Kumagai, N., Dohi, K., Tanimura, M., Sugiura, E., . . . Yamada, N. (2016). Combination of Urinary Sodium/Creatinine Ratio and Plasma Brain Natriuretic Peptide Level Predicts Successful Tolvaptan Therapy in Patients With Heart Failure and Volume Overload. International Heart Journal, 57(2), 211-219. https://doi.org/10.1536/ihj.15-330

Chicago Style (17th ed.) Citation

Fujimoto, Naoki, et al. "Combination of Urinary Sodium/Creatinine Ratio and Plasma Brain Natriuretic Peptide Level Predicts Successful Tolvaptan Therapy in Patients With Heart Failure and Volume Overload." International Heart Journal 57, no. 2 (2016): 211-219. https://doi.org/10.1536/ihj.15-330.

MLA (9th ed.) Citation

Fujimoto, Naoki, et al. "Combination of Urinary Sodium/Creatinine Ratio and Plasma Brain Natriuretic Peptide Level Predicts Successful Tolvaptan Therapy in Patients With Heart Failure and Volume Overload." International Heart Journal, vol. 57, no. 2, 2016, pp. 211-219, https://doi.org/10.1536/ihj.15-330.